We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSE
3376
DELISTED
Trinseo
TSE
$42.5K ﹤0.01%
18,409
-36,464
-66% -$113K
SLND icon
3377
Southland Holdings
SLND
$31.4M
$42.2K ﹤0.01%
9,209
+5,122
+125% +$25.3K
SBSW icon
3378
Sibanye-Stillwater
SBSW
$7.53B
$42.1K ﹤0.01%
9,670
NNDM
3379
Nano Dimension
NNDM
$343M
$42K ﹤0.01%
19,113
+2,479
+15% +$6.22K
LEVI icon
3380
Levi Strauss
LEVI
$9.39B
$41.8K ﹤0.01%
2,166
VUZI icon
3381
Vuzix
VUZI
$224M
$41.5K ﹤0.01%
30,747
-61,283
-67% -$84.5K
EVBN
3382
DELISTED
Evans Bancorp Inc
EVBN
$40.7K ﹤0.01%
1,447
-5,299
-79% -$143K
EGRX
3383
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$40.6K ﹤0.01%
7,246
-9,920
-58% -$43.2K
XNET
3384
Xunlei
XNET
$326M
$40.5K ﹤0.01%
24,097
+7,220
+43% +$12.1K
EH
3385
EHang Holdings
EH
$435M
$40.4K ﹤0.01%
2,978
-180
-6% -$3.04K
SST icon
3386
System1
SST
$17.5M
$39.9K ﹤0.01%
2,628
-435
-14% -$7.34K
MCRB icon
3387
Seres Therapeutics
MCRB
$48.4M
$39.9K ﹤0.01%
2,756
-4,317
-61% -$72K
ENOR icon
3388
iShares MSCI Norway ETF
ENOR
$96M
$39.8K ﹤0.01%
1,630
CANF
3389
Can-Fite BioPharma American Depositary Shares
CANF
$7.37M
$39.7K ﹤0.01%
770
-154
-17% -$7.29K
EM
3390
DELISTED
Smart Share Global Ltd
EM
$39.2K ﹤0.01%
46,105
-16,515
-26% -$14.5K
ZLAB icon
3391
Zai Lab
ZLAB
$2.62B
$39.1K ﹤0.01%
2,255
-177
-7% -$3.11K
RDZN icon
3392
Roadzen
RDZN
$112M
$38.9K ﹤0.01%
+17,511
New +$68.6K
JMIA
3393
Jumia Technologies
JMIA
$767M
$38.9K ﹤0.01%
5,535
-197
-3% -$1.21K
OTEX icon
3394
Open Text
OTEX
$6.04B
$38.7K ﹤0.01%
1,290
-760
-37% -$24.4K
ELUX
3395
DELISTED
AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
$38.3K ﹤0.01%
2,333
-370
-14% -$6.08K
VERI icon
3396
Veritone
VERI
$122M
$38.2K ﹤0.01%
16,894
-25,432
-60% -$90.3K
ALLK
3397
DELISTED
Allakos
ALLK
$38.1K ﹤0.01%
38,096
-65,442
-63% -$77.7K
XYF
3398
X Financial
XYF
$204M
$37.7K ﹤0.01%
8,745
MACK
3399
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$37.5K ﹤0.01%
2,480
-11,039
-82% -$164K
PMVP icon
3400
PMV Pharmaceuticals
PMVP
$63.5M
$37.3K ﹤0.01%
23,035
-39,693
-63% -$71.6K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.